Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Fibromyalgia

Author(s):  Oberlander Kevin

Issue:  Jan/Feb 2000 - Compounding for Pain Management
View All Articles in Issue

Page(s):  21-23

Fibromyalgia Page 1
Fibromyalgia Page 2
Fibromyalgia Page 3

Download in electronic PDF format for $75

Abstract:  Fibromyalgia is a collection of symptoms with an unknown cause. In this article, the author focuses on symptoms and treatment regimen (dietary recommendations, exercise, sleep, stress, nutritional support and topical treatments). A sidebar shows the body’s tender points and describes their location. The author concludes that if individuals and their physicians are willing to be persistent and integrate conventional practice with the tools of the compounding pharmacist, the patient will improve.

Related Keywords: aching muscles, amitriptyline, anti-inflammatories, baclofen, carbamazepine, cyclobenzaprine, depression, diclofenac, diet, exercise, fatigue, fibromyalgia syndrome, fibrositis, ibuprofen, ketamine, ketoprofen, lidacaine, muscular pain, nutritional support, piroxicam, PLO, polymyalgia, sleep, sleep deprivation, stress, tender points, transdermal gels

Related Categories: PAIN MANAGEMENT

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Fibromyalgia
Oberlander Kevin
Jan/Feb 2000
Pg. 21-23

Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 512

Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base
Allen Loyd V Jr
May/Jun 2017
Pg. 234

Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
May/Jun 2011
Pg. 245

Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel
Allen Loyd V Jr
Mar/Apr 2011
Pg. 157

Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Frankum James
, Ramsay Dale, Das Nandita G, Das Sudip K
Mar/Apr 2004
Pg. 101-105

Ibuprofen 400-mg and Cyclobenzaprine 2.5-mg Capsules
Allen Loyd V Jr
May/Jun 2020
Pg. 227

Women's Health Book Reviews
Reed-Kane Dana
Sep/Oct 1999
Pg. 357-359

The Role of Sex Hormones on Fibromyalgia Pain Mediators
Bramwell Bethany L
May/Jun 2010
Pg. 193-199

Topical Ketoprofen for Fibromyalgia
Manuel Julie
, Ford Gina
Nov/Dec 1998
Pg. 433

Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 513

Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 514

Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2008
Pg. 540

The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia
Cote Brianna
, Ross Bethany, Fortner Jeff, Rao Deepa
May/Jun 2018
Pg. 252-256

Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Goodwin Donald A
, Fuhram L Clifton
Nov/Dec 1999
Pg. 496-500

Feline Urologic Syndrome and Diet Formulation
Long Scott F
Sep/Oct 1999
Pg. 366-367

Ketamine HCl 10%, Gabapentin 6%, Baclofen 2%, Amitriptyline HCl 2% and Clonidine HCl 0.1% in PLO
Allen Loyd V Jr
Mar/Apr 2000
Pg. 133

Topical Ketamine in the Treatment of Complex Regional Pain Syndrome
Durham Melissa J
, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H
Mar/Apr 2018
Pg. 172-175

Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives
Trimble John
, Light Bob
May/Jun 2016
Pg. 250-256

Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Allen Loyd V Jr
May/Jun 2016
Pg. 231

Return to Top